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1324Objective: Endobronchial ultrasound–guided transbronchial needle aspiration (EBUS-TBNA) has been re-
ported to be an accurate and safe method to confirm a pathologic diagnosis of sarcoidosis. However, only
a few retrospective or small prospective studies have been published on EBUS-TBNA versus transbronchial
lung biopsy (TBLB), which has been the standard method for making a pathologic diagnosis of sarcoidosis
so far. The aim of this study was to compare the diagnostic yield of EBUS-TBNA and TBLB through a flexible
bronchoscope in patients with stage I and II sarcoidosis.
Methods:A total of 62 patients with suspected stage I and II sarcoidosis were included in this prospective study.
EBUS-TBNA was performed (2 lymph nodes, 2 needle passes for each lymph node), followed by TBLB
(5 biopsy specimens from multiple lung segments) in the same setting. The final diagnosis of sarcoidosis was
based on clinicoradiologic compatibility and pathologic findings.
Results: Of the 62 patients enrolled, 54 were given a final diagnosis of sarcoidosis. The diagnostic yield of
EBUS-TBNA and TBLB for sarcoidois by showing noncaseating epithelioid cell granuloma was 94% (stage
I, 97%; stage II, 88%) and 37% (stage I, 31%; stage II, 50%), respectively. The difference was statistically
significant (P< .001). One case of pneumothorax and 3 cases of moderate bleeding (7%) resulted from
TBLB, and 1 case of severe cough (2%) from EBUS-TBNA.
Conclusions: The diagnostic yield of EBUS-TBNA for stage I and II sarcoidosis is higher than for TBLB.
(J Thorac Cardiovasc Surg 2012;143:1324-9)Sarcoidosis is a systemic granulomatous disease of unknown
etiology. Although the clinical and radiologic findings are
highly reliable in the diagnosis of stage I sarcoidosis (bilateral
hilar and/or mediastinal lymphadenopathy) or stage II sar-
coidosis (bilateral hilar and/or mediastinal lymphadenopathy
and parenchymal abnormalities), proving the presence of
noncaseating epithelioid cell granulomas is indispensable
for its definitive diagnosis.1 Because the lungs are involved
in more than 90% of the cases, transbronchial lung biopsy
(TBLB) through a flexible bronchoscope has been the stan-
dardmethod formaking a pathologic diagnosis of sarcoidosis
so far.1 However, the diagnostic yield of TBLB, especially for
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The Journal of Thoracic and Cardiovascular Surthan sarcoidosis cannot be diagnosed or ruled out by TBLB.
Such diseases involve thoracic lymph nodes but not lungs
and show a similar radiographic appearance to stage I
sarcoidosis, such as metastatic carcinoma, lymphoma, and
various infectious diseases. The high complication rates
including pneumothorax and bleeding are another problem
associated with the procedure.
Transbronchial needle aspiration (TBNA) through
a flexible bronchoscope has been widely established as
a useful and safe clinical tool in the evaluation of hilar
and/or mediastinal lymphadenopathies.2,4 The addition of
endobronchial ultrasound (EBUS) guidance (EBUS-guided
TBNA; EBUS-TBNA) has greatly enhanced the diagnostic
yields and safety of bronchoscopy.5 Several investigators
have reported the excellent yield and safety of EBUS-
TBNA for diagnosing sarcoidosis by demonstrating nonca-
seating granulomas,3,6-12 and the procedure seems to be
more suitable than TBLB, which has been considered the
standard technique. However, only a few retrospective3,12 or
small prospective11 studies focused on EBUS-TBNA versus
TBLB have been published. We conducted a prospective
study comparing the diagnostic yield of EBUS-TBNA and
TBLB in patients with stage I and II sarcoidosis.
PATIENTS AND METHODS
Between April 2006 and December 2009, we carried out a prospec-
tive study that was approved by the institutional review board ofgery c June 2012
Abbreviations and Acronyms
CT ¼ computed tomography
EBB ¼ endobronchial biopsy
EBUS ¼ endobronchial ultrasound
EBUS-TBNA ¼ endobronchial ultrasound–
guided transbronchial needle
aspiration
TBLB ¼ transbronchial lung biopsy
TBNA ¼ transbronchial needle aspiration
Oki et al General Thoracic Surgery
G
T
SNagoya Medical Center (identifier: 2006-8) and registered with the
University Hospital Medical Information Network–Clinical Trials
Registry (identifier: UMIN000000507). Included in this study were
62 patients with suspected stage I or II sarcoidosis in the presence of
a compatible clinical and radiologic picture with enlarged hilar and/
or mediastinal lymph nodes, 10 mm or greater in the shortest diameter
on chest computed tomography (CT). Patients with pathologically
proven sarcoidosis were excluded. Informed consent was obtained
from all patients.
The primary outcome of this study was to compare the diagnostic yield
of EBUS-TBNA and TBLB for stage I and II sarcoidosis by demonstrating
noncaseating epithelioid cell granulomas. Secondary outcomewas to com-
pare the complication rates of these procedures.
All bronchoscopic procedures were performed with the patient under
local anesthesia using lidocaine and conscious sedation with midazolam
by staff pulmonologists. An endotracheal tubewas placed transorally under
bronchoscopic control,7,13 which facilitated repeated insertion and removal
of the bronchoscope; bronchoscopy was then performed in the standard
fashion to examine the endobronchial region. After that, EBUS-TBNA
was performed, followed by TBLB in a single session. Endobronchial bi-
opsy (EBB) was not performed except in 1 patient with an irregularity of
endobronchial mucosa. Bronchoalveolar lavage was not performed in
any patients.
EBUS-TBNA Procedure
EBUS-TBNA was performed using an EBUS bronchoscope (BF-
UC260F-OL8; Olympus; Tokyo, Japan) with a longitudinal convex ultra-
sound transducer at an ultrasonic frequency of 7.5 MHz, in combination
with an ultrasound processor (EU-C2000; Olympus). The EBUS broncho-
scope was passed through an endotracheal tube to the trachea, and then the
ultrasound transducer covered with a saline-filled balloon was brought into
contact with the airway wall and moved in all directions to identify the le-
sions for sampling. Once the target lesion was visualized by ultrasound im-
aging, needle aspiration using a 22-gauge needle (NA-201SX-4022;
Olympus) was performed under real-time EBUS guidance.
The specimen collected at the lumen of the needle was pushed out
by a central stylet and then blown by air from a syringe onto a glass
slide. The visible tissue fragment on the glass slide was then collected
and transferred into separate containers filled with formalin for histo-
logic examination, and the remaining specimen on the glass slide was
immediately smeared and fixed in 95% alcohol for cytologic examina-
tion. The residual specimen stored at the lumen of the needle and cath-
eter was then washed and flushed into saline for culture for
microbiologic analysis. The pathologic specimens obtained by EBUS-
TBNA in their containers labeled with the lymph node station14 were
then submitted to the pathologist for interpretation. Rapid on-site
cytologic evaluation was not performed. EBUS-TBNA was performed
for 2 easily accessible, suspicious, large lymph nodes with 2 punctures
at each location.The Journal of Thoracic and CarTBLB Procedure
After EBUS-TBNA was performed, the EBUS bronchoscope was re-
moved and a standard bronchoscope (BF-1T260; Olympus) was inserted
into the trachea. TBLB using a standard-sized biopsy forceps (FB-231D;
Olympus) was performed under fluoroscopic guidance. Five visible frag-
ments were obtained from multiple lung segments, typically from both
middle and lower lobes in stage I disease and visible parenchymal lesions
in stage II disease in a manner similar to that previously described.4 The
pathologic specimens transferred into separate containers filled with for-
malin were then sent to the pathologist for examination. A chest radiograph
was obtained routinely to identify pneumothorax 2 hours after the
procedures.
Diagnosis
Each histologic and cytologic specimen was interpreted separately as
‘‘positive,’’ ‘‘suspicious,’’ or ‘‘negative’’ for sarcoidosis with noncaseating
epithelioid cell granulomas by an experienced pathologist. ‘‘Suspicious’’
findings were regarded as negative in our analysis. The final diagnosis of
sarcoidosis was based on the clinicoradiologic compatibility at the time
of the procedures, during the clinical follow-up period, as well as the path-
ological findings of noncaseating granulomas and with the exclusion of
other causes of granulomas.
The chest radiographic stagewas based on the findings of a posteroante-
rior chest radiograph or chest CT in patients with obscure radiographic
findings for staging. Stage I was defined as hilar and/or mediastinal aden-
opathy without pulmonary infiltrates and stage II as hilar and/or mediasti-
nal adenopathy with pulmonary infiltrates.
Data Analysis
Statistical analyses were performed using a statistical software program
(PASWStatistics 18; SPSS, Inc, Chicago, Ill). Means and percentages were
presented as appropriate. Diagnostic yields or complication rates of both
modalities were compared using Fisher’s exact test.RESULTS
Patients
A total of 62 patients were enrolled in this study. Charac-
teristics of patients and a diagnostic flow chart were sum-
marized in Table 1 and Figure 1, respectively. Among the
62 patients, 44 (71%) had suspected stage I sarcoidosis
and 18 (29%) had suspected stage II sarcoidosis. Both
EBUS-TBNA and TBLB were completed in 60 patients,
but the procedures were terminated half way in 2 residual
patients owing to a severe cough after examining the first
lymph node with EBUS-TBNA and moderate bleeding at
the initial use of TBLB. EBUS-TBNA and/or TBLB
showed noncaseating epithelioid cell granulomas in 51 pa-
tients, all of whomwere judged to have sarcoidosis from the
clinicoradiologic compatibility. The procedures provided
a diagnosis of tuberculosis in another 2 patients. Of the re-
maining 9 patients without definitive pathologic findings, 3
patients with suspected pathologic findings for sarcoidosis
or suggestive of ocular sarcoidosis were judged to have sar-
coidosis, and 6 patients had other diseases (1 lymphoma,
1 immunoglobulin G4–related lymphadenopathy, 4 nonspe-
cific lymphadenitis). Of the 4 patients given a diagnosis of
nonspecific lymphadenitis, 2 patients previously underwent
nondiagnostic bronchoscopy and 1 patient underwentdiovascular Surgery c Volume 143, Number 6 1325
TABLE 1. Patient characteristics
Characteristics Data
No. of patients 62; all Japanese
Mean age, y (range) 49.4  15.6 (18-74)
Gender (male/female) 26/36
Smoking history
Never-/ex-/current-smoker 27/15/20
Main reason for consultation
Chest radiographic abnormalities 35
Clinical symptoms 27
(Respiratory/ocular/arrythmia/nonspecific) (13/10/2/2)
Chest radiographic staging
Stage I/II 44/18
Serum angiotensin-converting enzyme
Elevation/nonelevation 25/37
Bronchoscopy
Initial bronchoscopy/previous
nondiagnostic bronchoscopy
52/10
Median follow-up duration, mo (range) 21.5 (1-48)
Data are presented as number or mean  standard deviation unless otherwise stated.
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Snondiagnostic EBUS-TBNA again shortly afterward. All 4
patients showed no clinical or radiologic deterioration dur-
ing the follow-up period (range, 13-42months). Thus, a total
of 54 patients were given a final diagnosis of sarcoidosis.
Median follow-up duration was 21.5 months.Diagnostic Yield
A total of 123 lymph nodes with a mean shortest diameter
of 16.2 mm (range, 10-33 mm) were examined by EBUS-
TBNA. The lymph node locations examined were as fol-
lows: station 2R (n ¼ 4), 3p (n ¼ 1), 4R (n ¼ 42), 4L
(n ¼ 2), 7 (n ¼ 39), 10R (n ¼ 3), 11R (n ¼ 28), and 11L
(n ¼ 4).
EBUS-TBNA confirmed a diagnosis of sarcoidosis by
identifying noncaseating epithelioid cell granulomas in 37
(97%) of 38 patients with stage I disease, 14 (88%) of 16
patients with stage II disease, and overall 51 (94%) of 54
patients (Table 2). The sensitivity, specificity, and accuracy
of EBUS-TBNA for pathologic diagnosis of sarcoidosis
were 94%, 100%, and 95%, respectively. Cytologic spec-
imens contained diagnostic material in 41 (76%) of 54 pa-
tients (Figure 2, A) and histologic specimens in 42 (78%) of
54 patients (Figure 2, B). Among 107 nodal lesions exam-
ined in the 54 patients with a final diagnosis of sarcoidosis,
noncaseating epithelioid cell granulomas were demon-
strated in 91 lesions (85%).
TBLB allowed a pathologic diagnosis of sarcoidosis in
11 (31%) of 36 patients with stage I disease, 8 (50%) of
16 patients with stage II disease, and overall 19 (37%) of
52 patients (Table 2). In stage II disease, TBLB provided di-
agnostic material in 7 (58%) of 12 patients with bilateral
lung lesions and 1 (25%) of 4 with unilateral lung lesions.
The sensitivity, specificity, and accuracy of TBLB for1326 The Journal of Thoracic and Cardiovascular Surpathologic diagnosis of sarcoidosis were 37%, 100%, and
45%, respectively. All 19 patients who were provided diag-
nostic material from TBLB were also provided diagnostic
material from EBUS-TBNA. The diagnostic yield of
EBUS-TBNA was significantly higher than that of TBLB
in stage I or II sarcoidosis (stage I, P< .001; stage II,
P ¼ .027; overall, P<.001).
Safety
One case of pneumothorax and 3 of moderate bleeding
(4/61 patients; 7%) resulted from TBLB; in another case
(1/62 patients; 2%) a severe cough during EBUS-TBNA
prevented continuation of the bronchoscopy (P ¼ .21).
DISCUSSION
Our study demonstrated that the diagnostic yield of
EBUS-TBNA for patients with stage I or II sarcoidosis
was significantly higher than that of TBLB. TBLB alone
did not provide any information for diagnosis in addition
to the results of EBUS-TBNA in our population. Although
a few retrospective3,12 or small prospective11 studies have
been published so far, to the best of our knowledge, this
study, which was conducted after our preliminary study7
and registered with a clinical trials registry in 2006, is quite
original in comparing the diagnostic yield of EBUS-TBNA
and TBLB by showing noncaseating granulomas for stage
I and II sarcoidosis.
Since the development of flexible bronchoscopes in the late
1960s, bronchoscopy including TBLB, EBB, or TBNA has
been a conventional technique for the pathologic diagnosis
of sarcoidosis.2,4,15,16 However, despite the widespread use
of these conventional procedures, the results are often
unsatisfactory. A recent multicenter prospective trial in
2010 with 15 participating institutions demonstrated that
the diagnostic yield of bronchoscopy with flexible scopes
for sarcoidosis was 45%, even though 40% of patients had
stage II-IV disease.10 The diagnostic yield of TBLB depends
on the bronchoscopist’s skill, the number of sampled speci-
mens, and the chest radiographic staging. The diagnostic
yield of TBLB for stage I sarcoidosis is far from satisfactory.
Although the reported yield seems to be acceptable, several
investigators commented that the high diagnostic yield of
conventional bronchoscopy in patients with suspected
sarcoidosis reported in early studies cannot be realized in
current daily practice.6,17 In fact, recent studies2,3,11,18 have
demonstrated that the lower diagnostic yield of TBLB
ranged from 12% to 43% for stage I sarcoidosis against
a diagnostic yield of more than 70% in early studies.15,16
Additionally, a recent study suggested the diagnostic yields
of TBLB were not different between patients with
parenchymal disease (stage 0/I sarcoidosis) and those
without it (stage II/III/IV sarcoidosis).18 The diagnostic yield
of TBLB reported in recent publications seems to be lower,
and likewise the yield in the present study was lower than ingery c June 2012
Suspected stage I/II sarcoidosis n = 62
EBUS-TBNA n = 62
TBLB n = 60, 
Due to severe cough during EBUS-TBNA n = 1, 
moderate bleeding  during TBLB n = 1
TBLB n = 19
Final diagnosis of sarcoidosis n = 54
By EBUS-TBNA n = 51,
Epithelioid cell granulomas n = 51 Other findings n = 2
Tuberculosis n = 2
No definitive findings
n = 9
Suspicious pathological findings  n = 2
Few epithelioid cells and giant cells n = 1 
Crushed granuloma n = 1 
Ocular lesions n = 1
Lymphoma n =  1
IgG4-related lymphadenopathy n = 1
Tuberculosis n =  2
Non-specific lymphadenitis n =  4
Other diseases n = 8
51
Mediastinoscopy n = 1
Orbit biopsy n = 1
Clinical follow-up n = 4
3 6 2
No TBLB n = 2 
FIGURE 1. Diagnostic flow chart. EBUS-TBNA, Endobronchial ultrasound–guided transbronchial needle aspiration; TBLB, transbronchial lung biopsy;
IgG, immunoglobulin G.
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Searly studies. The reasons are unclear but may relate to the
recent advances in imaging technologies, especially CT tech-
nologies. High-resolution CT provides clear thoracic images
that serve to identify small, early-stage lesions.Consequently,
the opportunities to encounter patients with suspected sar-
coidosis, especially early-stage sarcoidosis, seem to be in-
creasing. Although chest CT is considered unnecessary for
diagnosis of most patients with sarcoidosis,1 preprocedural
chest CTwas obtained in almost all patients enrolled in recent
trials, including ours, focusing on bronchoscopic diagnosis of
sarcoidosis. The staging of sarcoidosis should be based on the
posteroanterior chest radiograph, and the obscure findings of
chest radiographs can be clarified by chest CT. Consequently,
even in the same stage, recent studies may include more pa-
tients with mild abnormalities than earlier ones.
The development of the echo-endoscopes has dramatically
changed theway of evaluatingmediastinal lesions. The accu-
racy of transesophageal endoscopic ultrasound–guided fine
needle aspiration or EBUS-TBNA for mediastinal lesion
has been reported to be extremely high.5,19-24 In the
mediastinal nodal staging in lung cancer, several authors
have reported that the sensitivity of either or a combination
of these modalities surpasses that of mediastinoscopy,TABLE 2. Diagnostic yield of EBUS-TBNA versus TBLB for sarcoidosis
Chest radiographic staging
EBUS-TBNA
Patients diagnosed/examined (%)
Stage I 37/38 (97)
Stage II 14/16 (88)
Total 51/54 (94)
EBUS-TBNA, Endobronchial ultrasound-guided transbronchial needle aspiration; TBLB, t
The Journal of Thoracic and Carwhich has been thought to be the ‘‘gold standard’’ for
mediastinal exploration.20,21 These needle aspiration
procedures are useful for diagnosing not only malignant
disease but also benign disease including sarcoidosis. The
sensitivity of endoscopic ultrasound–guided fine needle
aspiration and EBUS-TBNA for sarcoidosis has been re-
ported to range from 82% to 100%10,17,25-27 and 71% to
93%,3,6-12 respectively. In our study, the diagnostic yield of
EBUS-TBNAwas 94%, which was consistent with the result
of 93% in our preliminary study.7 Our diagnostic yields are at
the higher endofwhat has been reportedbefore, but they seem
not surprisingly high. The reason for our high diagnostic
yields may relate to the number of lesions punctured. The di-
agnostic yield per patient resulted from EBUS-TBNA for 2
lymph nodes, although the diagnostic yield per lesion was
85%. In the study of Wong and associates,6 the comparable
diagnostic yield of 92% in relation to our yield was obtained
byEBUS-TBNA for themeannumber of 1.2 lymphnodes per
patient. Similarly, Nakajima and colleagues3 demonstrated
that the diagnostic yield of 91% resulted from EBUS-
TBNA for the mean number of 1.3 lymph nodes per patient.
EBUS-TBNA, which is a highly accurate and less invasive
method, will surely decrease the need for second diagnosticTBLB
P valuePatients diagnosed/examined (%)
11/36 (31) <.001
8/16 (50) .027
19/52 (37) <.001
ransbronchial lung biopsy.
diovascular Surgery c Volume 143, Number 6 1327
FIGURE 2. Specimens obtained by endobronchial ultrasound–guided
transbronchial needle aspiration in patients with sarcoidosis. A, Cytologic
specimen showing nonnecrotizing epithelioid cell granuloma. (Papanico-
laou stain, original magnification 3200.) B, Histologic specimen contain-
ing noncaseating epithelioid cell granulomas (hematoxylin and eosin stain,
original magnification 3100).
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Sprocedures including mediastinoscopy in patients with sus-
pected sarcoidosis. The requirement of a second procedure
for patients with a nondiagnostic EBUS-TBNA result de-
pends on the probability of alternative disease. For nonsymp-
tomatic patients with typical clinicoradiologic features of
sarcoidosis, close clinical observation may be sufficient,28
whereas the accuracy ofEBUS-TBNA to establish an alterna-
tive diagnosis of malignant lymphoma may be insufficient.29
In our study, 1 patient with negative EBUS-TBNA results un-
derwent mediastinoscopy, which established the diagnosis of
lymphoma. In patients with presumptive malignancy as alter-
native diseases,mediastinoscopy still plays an important role.
To date, a few studies have compared the diagnostic yield
of EBUS-TBNA with other bronchoscopic modalities
for sarcoidosis.3,9,11,12 In the study of Tremblay and
associates,9 a total of 50 patients with suspected stage I or
II sarcoidosis were randomized to undergo EBUS-TBNA
and conventional TBNA using a 19-gauge needle. The diag-
nostic yield of EBUS-TBNA was significantly higher than
that of conventional TBNA (83% vs 54%). In the study
of Nakajima and colleagues,3 the diagnostic yield of1328 The Journal of Thoracic and Cardiovascular SurEBUS-TBNA, TBLB, and bronchoalveolar lavage for 38
patients with suspected stage I and II sarcoidosis was retro-
spectively analyzed. They demonstrated that the diagnostic
yield of EBUS-TBNA for sarcoidosis was significantly
higher than that of TBLB (91% vs 40%). The results of
the present study were comparable with those of their retro-
spective study.
Althoughour results could not show statistically significant
differences owing to the small sample size, EBUS-TBNA ap-
pears to have the advantage of a lower complication rate com-
pared with TBLB from previous reports. Pneumothorax and
bleeding are widely known complications associated with
TBLBwith an occurrence rate of 1% to 5% and 9%, respec-
tively.30 On the other hand, the safety of EBUS-TBNA is
widely established. One article reviewing 20 publications
on EBUS-TBNA demonstrated no serious complications
had occurred.5 The fact that EBUS-TBNA does not require
fluoroscopy may also be a potential advantage over TBLB,
which is often performed under fluoroscopy in terms of radi-
ation exposure for both examiner and patients.
The major limitation of our study is the nonrandomized
design. In our study, EBUS-TBNAwas performed followed
by TBLB in a single session in each patient. The order of the
procedures might affect the results of the study. Another
potential limitation is that we did not perform EBB, which
has been reported to play a complementary role to TBLB in
terms of diagnostic yield in US studies.31 TBLB is the
standard method for pathologic diagnosis of sarcoidosis in
Japan, whereas EBB is somewhat underused because of
the limited role for detecting sarcoidosis in Japanese pa-
tients.32 To elucidate in more detail, randomized studies
comparing EBUS-TBNA with other biopsy modalities
may be required.
In conclusion, the diagnostic yield of EBUS-TBNA for
stage I and II sarcoidosis is clearly higher than for TBLB.
Although this procedure is available in only a limited num-
ber of institutions at the present time, the accumulation of
study results on the usefulness of this procedure will lead
to its greater availability in the near future. If so, we recom-
mend EBUS-TBNA rather than TBLB for patients in whom
stage I or II sarcoidosis is suspected.References
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